Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan

被引:0
|
作者
Tasaka, Yuichi [1 ,2 ]
Tanaka, Akihiro [1 ,2 ,5 ]
Yasunaga, Daiki [1 ,2 ]
Asakawa, Takashige [2 ,3 ]
Araki, Hiroaki [4 ]
Tanaka, Mamoru [1 ,2 ]
机构
[1] Ehime Univ Hosp, Div Pharm, 454 Shitsukawa, Toon, Ehime 7910295, Japan
[2] Ehime Soc Hosp Pharmacists, 454 Shitsukawa, Toon, Ehime 7910295, Japan
[3] Saiseikai Saijo Hosp, Dept Pharm, 269-1 Tsuitachi, Saijo, Ehime 7930027, Japan
[4] Shujitsu Univ, Sch Pharm, Naka Ku, 1-6-1 Nishigawara, Okayama, Okayama 7038516, Japan
[5] Ehime Univ Hosp, Div Pharm, 454 Shitsukawa, Toon, Ehime 7910295, Japan
关键词
Pharmaceutical intervention; Adverse drug reaction; Potential drug-related problem; Elderly patients; Renal dysfunction; Polypharmacy;
D O I
10.1186/s40780-018-0125-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundPharmaceutical intervention enables safe and effective pharmacotherapy by avoiding of adverse drug reactions (ADRs) and efficacy attenuations. Many prescriptions require optimization, and pharmaceutical interventions are inextricably associated with the prevention of potential drug-related problems (DRPs). Although the analysis and understanding of pharmaceutical interventions can lead to improvement in prescription, the analysis of routine pharmaceutical interventions in Japan in insufficient. Thus, we conducted this study to understand potential DRPs by analyzing routine pharmaceutical interventions made by pharmacists in Japan.MethodsPharmacists register the details of pharmaceutical interventions (excluding personal patient information) in a web-based database. We classified data of pharmaceutical interventions into 13 DRP types, 43 DRP subtypes, and 10 intervention categories (e.g., avoidance of serious ADRs and renal dosing recommendations). These data were analyzed with a focus on renal dysfunction and polypharmacy.ResultsDuring the study period, 2376 pharmaceutical interventions were performed. Overall, 68.2% of pharmaceutical interventions were for patients aged over 65years. The most frequently detected potential DRP was overdosage, followed by omission of prescription, contraindications, and duplication of a drug with similar effect. The main cause of contraindication and overdosage was renal function deterioration, and that of polypharmacy was duplication of a drug with similar effect. Using our original evidence-based approach, we found that 2376 pharmaceutical interventions prevented ADRs for 1678 drugs, with potential cost savings of up to USD 2,657,820.ConclusionsOur results indicate that the analysis of routine pharmaceutical interventions is beneficial for detecting potential DRPs. Our findings also show that, in an aging society, pharmacists have an important role in providing medication safety, with potential cost savings.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Drug-related problems in a medicinal intensive care unit detected by clinical pharmacists on bedside rounding teams
    Nguyen, Khanh H. P.
    Vo, Lan H.
    Nguyen, Dung T.
    Truong, Hai N.
    Vu, Hoai T. T.
    Khong, Thang T.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (06) : 1774 - 1774
  • [32] Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program
    Ensing, Hendrik T.
    Koster, Ellen S.
    Dubero, Dasha J.
    van Dooren, Ad A.
    Bouvy, Marcel L.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2019, 15 (03): : 267 - 278
  • [33] Medication safety in hospitals Integration of clinical pharmacists to reduce drug-related problems in the inpatient setting
    Blassmann, Ute
    Morath, Benedict
    Fischer, Andreas
    Knoth, Holger
    Hoppe-Tichy, Torsten
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2018, 61 (09) : 1103 - 1110
  • [34] Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability
    Ahmed, Norhan Attia
    Fouad, Ehab Ahmed
    El-Asheer, Osama M.
    Ghanem, A. S. M.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Drug-Related Problems and Pharmacists' Interventions in Hypertensive Outpatients: A Multicenter Prospective Study in 3 Vietnamese Hospitals
    Huynh, Bon Huu
    Nathisuwan, Surakit
    Tragulpiankit, Pramote
    Nguyen, Vinh Dai
    Huynh, Nam Huu
    Vu, Thu Le Anh
    Huynh, Loc Thi Hong
    Vo, Ha Thi
    JOURNAL OF PHARMACY TECHNOLOGY, 2023, 39 (06) : 259 - 268
  • [36] Drug-related problems in older people after hospital discharge and interventions to reduce them
    Garcia-Caballos, Marta
    Ramos-Diaz, Francisco
    Juan Jimenez-Moleon, Jose
    Bueno-Cavanillas, Aurora
    AGE AND AGEING, 2010, 39 (04) : 430 - 438
  • [37] Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrospective study in a French university hospital
    Alkanj, Ahmad
    Godet, Julien
    Johns, Erin
    Gourieux, Benedicte
    Michel, Bruno
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [38] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: a randomized controlled trial
    Pourrat, Xavier
    Roux, Clarisse
    Bouzige, Brigitte
    Garnier, Valerie
    Develay, Armelle
    Fraysse, Martial
    Halimi, Jean-Michel
    Allenet, Benoit
    Giraudeau, Bruno
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 212 - 213
  • [39] Identification of drug-related problems and pharmacists interventions in asthmatic patients at a private tertiary care facility-Pakistan
    Khan, Aziz Ullah
    Ali, Iftikhar
    Zafar, Roheena
    Khalil, Abdul
    ARCHIVES OF PHARMACY PRACTICE, 2015, 6 (02) : 33 - 37
  • [40] Drug-related problems among pediatric intensive care units: prevalence, risk factors, and clinical pharmacists’ interventions
    Nasrin Shirzad-Yazdi
    Sajjad Taheri
    Afsaneh Vazin
    Eslam Shorafa
    Seyedeh Narjes Abootalebi
    Katayoon Hojabri
    Fatemeh Javanmardi
    Mojtaba Shafiekhani
    BMC Pediatrics, 24 (1)